secwatch.observer — SEC 8-K summary
======================================

Issuer:     AN2 Therapeutics, Inc. (ANTX)
CIK:        0001880438
Form:       8-K
Filed at:   2026-03-10T23:59:59+00:00
Accession:  0001193125-26-099169
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AN2 Therapeutics announces $40M private placement of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Gross proceeds ~$40M from sale of 8.25M shares at $2.85/share and 5.79M pre-funded warrants at $2.84999/warrant.
- Investors include Coastlands Capital, Commodore Capital, Vivo Capital; Leerink Partners as placement agent.
- Pre-funded warrants have $0.00001 exercise price, exercisable immediately, subject to 9.99% beneficial ownership blocker.
- Closing expected March 10, 2026; resale registration statement to be filed within 30 days after closing.
- Net proceeds for general corporate purposes and working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1880438/000119312526099169/0001193125-26-099169-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1880438/000119312526099169/d14366d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-099169

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer